3 lotion companies fail to prove ‘skin whitening’ claims, fined

NEW DELHI:  Advertisements on e-commerce platforms that claim certain body lotion can whiten your skin in just minutes always sounded fictitious. What you doubted has turned out to be true. In three recent cases, companies have admitted to the Central Consumer Protection Authority (CCPA) that these were exaggerations and they resorted to such claims of “unique selling point (USP)” to just come up on e-commerce platforms.

In orders passed by the CCPA in Feb against four companies selling whitening creams and body lotion, including the three which cited USP, the consumer watchdog has recorded how the companies failed to substantiate their claims. They withdrew their advertisements from e-commerce platforms after the authority issued notices to them.

In all these cases, investigations by the Bureau of Indian Standards confirmed that the companies failed to provide any scientific validation to their claims or any proof to support their claims. It has imposed fines on these entities and instructed them not to make such unverified and unsubstantiated claims. It cautioned them of a Rs 50 lakh fine for repeat of offence.

Interestingly, in all the four cases, the companies claimed they were unaware of the law against misleading advertisements of the CCPA.

Related Posts

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Aytu BioPharma launches depression drug EXXUA in U.S. market

DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session